This Sources Sought opportunity from Department Of Veterans Affairs was posted on January 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6640--VISN 15- Clinical Laboratory Chemistry Immunochemistry Instrumentation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
General Info
Place of Performance
Department of Veterans Affairs VISN 15, KS, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Leavenworth VAMC  18 FT L x 8 FT W East wall 22 L x 15 W North area Marion VAMC  15 L X 17 W Poplar Bluff VAMC 26 FT Long x 7 ft Wide Cape Girardeau HCC 10.5 ft long x 3 ft wide, also add 3 ft to get behind analyzer St. Louis VAMC  6 FT x 4 9 (6 instruments) Jefferson Barracks Division  11 FT x 5 FT Topeka VAMC  Has a U configuration 18 L x 8 W East wall 18 L x 7 W North wall 23 L x 14 W Middle area Wichita VAMC  127 x 49 does not include any peripherals such as printer/monitor/etc. There is only about 15-inch clearance space behind analyzers backing up to a wall; no additional space in front. Sufficient capacity and throughput to meet the volume and service demands as defined in TBD. A bi-directional, bar-coded computer interface compatible with the current VA laboratory information system. The fully operational interface (both hardware and software) shall be immediately available for implementation to the VA computerized hospital information system. Equipment must be able to support multiple barcode formats (Code 39, Code 128) that may be enabled concurrently. Equipment must accept, at a minimum, 10 characters in specimen identifier that is alpha and numeric concurrently that may be enabled concurrently. A barcode reading accuracy rate of 99% or greater. Integrated modules must only require one system control center (computer and screen) to simplify operations. Equipment must have the ability to monitor instrument performance Continuous monitoring of vital instrument functions with immediate operator notification of failure(s). A record(s) of the vital instrument function failure(s) must be maintained and stored electronically on-board the equipment. Ability to store and retransmit records (24 hours of maximal instrument throughput) in case of interface outage. Capability to capture, store and print the following information: Instrument maintenance information. Patient demographic information. Specimen results. The ability to print patient reports in chartable medical record format for use during downtime operations. On board reagent inventory management system must have: Analyzers must be capable of monitoring reagent usage, maintaining and storing on board supplies/reagents for 24 hours of patient testing on the combined platform, and providing reagent inventory upon request, in real time. A system that provides reagent data to include but not limited to lot number, expiration date, and the number of remaining tests available for use on the analyzer(per analyte). Bar coding of reagents and the ability to track reagent containers throughout the testing process through the use of bar code technology. A barcode reading accuracy rate of 99% or greater. Minimal operator intervention when introducing a STAT specimen or when changing a routine specimen to a STAT specimen. The introduction of a STAT specimen must not compromise existing programmed testing. Instruments must be available for full front loading of samples, reagents, consumables and bulk solutions with minimal disruption of workflow if the automation line is down for any reason and STATs must take priority over routine testing. Primary tube sampling from evacuated collection tubes of various sizes and from various manufacturers. Capable of handling all routine sample collection tubes plus other various sized sample containers, e.g. sample cups (0.5, 1.0, and 2.0 ml), carrier tubes and tube inserts. The ability to continuously load patient specimens. The ability to detect short samples. Instrument must have liquid level sensing, clot, foam and bubble detection with alert notification. Instrument must perform specimen integrity evaluation on all samples as needed at no additional cost. This is, the ability to detect and flag for hemolysis, lipemia and icterus. Hemolysis, icterus and lipemia interference threshold for analytes shall be provided/validated by the manufacturer. The Government reserves the right to review all proposals based on individual merit and make a medical based decision on the system(s) offering least interference and provides best overall value to the Government. Analyzers must have minimal carryover and not require the use of disposable pipette tips or aliquots or specific aspiration order of assays. The ability to perform testing with limited interference from human anti-mouse or heterophilic antibodies, high dose hook effects, and other interferences assuring the highest result integrity. Instruments must offer extended linearities to reduce the number of dilutions and increase first pass resulting. The capability to auto dilute a test when defined limits are exceeded. For sites using autoverification, the ability must exist to accept a download of an order from the sites existing Data Innovations middleware. (Contractor shall indicate on TBD Info each analyte that can be set to auto dilute on each instrument model offered.) The capability to program a test to perform a repeat analysis, reflex, and auto-rerun. The repeat test result must be able to cross the interface and overlay the initial result. Safety features to avoid unnecessary exposure to biohazardous and chemical material. The exposure to and the volume of biohazardous and chemical material generated by the equipment must be minimal and require a minimum amount of handling. For those sites requiring back up analyzers, it would be desirable for the backup analyzer to be a mirror image or have the same reagent requirement as the primary analyzer. Ability to store and retransmit records (24 hours of maximal instrument throughput) in case of interface outage. Equipment relocation and possible reinstallation should the equipment need to be moved due to construction or laboratory redesign at no additional cost for one (1) relocation within each site. Ability to maintain use of the equipment if the Automation Line were to be in an off-line status for service or maintenance. Open channel chemistry availability for adaptation of commercially available reagents not produced by vendor. The vendor must have limited factory recalls of reagents and instrumentation. Please include all factory recalls for the last 18 months. Surveillance package within a Business Performance platform that provides automated reports to regulatory bodies for infectious disease management programs such as Covid-19, monitoring diagnostic rates by postal code, testing sites, ordering provider, gender, or age. Analyzer utilizes windows operating software or other VA approved operating system. Vendor will complete and return the following attachments: 6550 Pre-Procurement Assessment MDS2 Manufacturer Disclosure Statement for Medical Device Security Instrument Quality Control System On-board QC data management system with minimum storage capacity of 600 QC files and includes Levy-Jennings graphs. Analyzer must have the ability to capture, store and electronically transfer QC data to BIORAD, Technopath or other Quality Control program or disk storage. Shall provide ability to peer review external comparison data for quality control materials and have inter-laboratory peer comparisons forwarded monthly. Average peer group size shall be sufficient to enable adequate monitoring and comparison of results. A peer group shall be at least 10 peers for an established lot number of quality control. Ability to on-line document QC out of range. Ability to read barcoded QC. Ability to store quality control values for second lot number during crossover studies. Ability to retain quality control data from second lot number when put into use. Ability to edit or correct errors of QC files manually. The quality control material shall be included in the contract for all tests in use (credit towards purchase). Contractor shall provide lot number coordination to ship the same lot (minimum suggest outdate for controls lots shall be more than one year). Capability to detect and alert operator of out of range quality control results via flagged results on QC printout and visual alerts on display monitor. Patient testing is disabled if QC failure occurs. The technology must allow electronic transmission of quality control data to BIORAD, Technopath or other Quality Control program through the VA owned Data Innovations Middleware. For general chemistry tests, when more than one lot of a given reagent has a valid calibration on the analyzer and quality control material is programmed to run as a control (in the control mode). The ability to run old lots of QC concurrently with new lots for parallel testing. Quality control material will automatically be run on all lots of those reagents when the respective test is requested. Quality control results will be easily distinguishable i.e., identified by reagent lot number or similar mechanism, on instrument printout or display monitor. Operator may select to run a test on only a specified lot of reagent even though more than one lot has a valid calibration. Quality control frequency not to exceed once/24 hours/instrument platform. Minimum quality control frequency for NA/K/CL not to exceed once/8 hours/instrument platform. Reagents Convenient Reagent and Standard Use. On board reagent stability sufficient to accommodate both high and low volume use. The ability to detect and alert operator of low liquid levels and the potential of depletion. The ability to unload/remove empty reagent containers from the equipment during operation without interrupting testing in progress. The ability to calibrate and support more than one (1) reagent lot of the same reagent on the equipment at the same time. The capability to calibrate assays during test run without aborting the run. Extended Calibration life for most analytes with little or no daily/weekly calibration. Automatic calibration of electrolytes. Analyzer has the ability to notify user when calibration is within one hour of expiration. Liquid calibrators for most or all tests with minimal calibrator preparation. List any calibrators that require preparation and the required process. Long calibration stability. The capability of incorporating other manufacturer s reagents. The capabilities to store, print, and retrieve calibration data. Each clinical chemistry module must have a minimum 70 reagent slots and each immunoassay analyzer must have a minimum of 47 reagent slots to allow for maximum load up of reagents to increase walkaway time and reduce technologist intervention. Reagents with little or no reagent preparation for most or all tests. Instrument shall have capability to flag new reagent packs prior to quality control use. Enzyme verifiers available to periodically check performance of enzyme tests that lack standards. IDMS traceable Creatinine reagent. Minimal requirements for sample pre-treatment. Minimal requirements for reagent/calibrator preparation. Reagents have prolonged shelf life and stability once opened and on board the analyzer. Various reagent sizes to allow economical usage by both small and large laboratories in VISN 15. Offeror shall characterize each method and provide exact vendor guaranteed minimum linearity/AMR, CRR limits in TBD. Contractor shall include linearity material for AMR verification. As new methods are released for the instrument, the updates are automatically enabled promptly and at no cost to user. Offer shall provide AMR Calibrator Values and Calibrator frequency in TBD Offer shall provide Percent (%) CV on assays in TBD. Interface Requirements The Contractor shall be responsible for providing all hardware required for the connection, implementation, and operation of the interface to the universal interface and any incremental fee that is required each time an instrument is added to an existing universal interface system (see TBD). The Contractor shall provide any and all necessary software support for ensuring that successful interfacing has been established. Specific requirements for the communication of the data streams will be unique to the instrument system involved and dictated by the manufacturer itself. Information necessary to make the determination for type and amount of interfacing equipment is supplied in TBD. If a site already has a universal interface system, the Contractor is responsible for everything leading up to the connection to the software system, including any incremental fee required to add additional equipment (e.g. licenses, ports/cards, cables, software, etc.) to the universal interfacing system. If a site does not have a universal interface and one is needed to optimally interface the instrument, then the Contractor is responsible for the acquisition of the universal interface box and everything else needed to connect with VA computerized hospital information system. If there are any software upgrades in the instrument during its life, the Contractor is responsible for seeing that the interface can accommodate any changes in the data stream going to the VA computerized hospital information system. The Specimen Management system must be computer interface compatible with the current VA laboratory information system and existing universal interface. The fully operational interface (both hardware and software) shall be immediately available for implementation to the VA computerized hospital information system. Auto-verification Support Contractor shall collaborate with each lab to write/develop protocols to establish customer configurable rules to enhance workflow management and productivity through existing Data Innovations Middleware solutions. This collaboration may be accomplished by direct support by the contractor, by a subcontract to a mutually agreed upon secondary vendor or a combination of both. All rules necessary to support auto-verification will be written and tested prior to go live date for the new analyzer configurations. Support will be provided to assist with any issues that are found during the go live process for auto-verification and for at least one-month post go live. Analyzers should allow for auto-verification to be accomplished at each VA facility through existing VA owned Data Innovations Middleware solutions. Required Services: Autoverification Workflow Build and Deployment: Contractor must provide all necessary servers for a live environment, test environment and hot back up. Perform assessments of the autoverification workflow to gather and understand the rule logic needs. Design and implement autoverification rule set to enable analyzers and automation to connect through the VA Lab IM to properly file autoverified results in the VISTA LIS. DI Rules can include but are not limited to the following Rule types: QC Evaluation Rerun Comparison Error Flags Result Formatting Serum Indicies Reference Ranges Critical Results Delta Check Calculations Specimen Integrity Reflex Tests LIS Formatting Validate or Hold for Review Work with the Laboratory LIM s, interface the VISTA/ORACLE Cerner LIS with vendor provided Middleware for automation tracks. Work with the Laboratory LIM s to interface the VISTA/ORACLE Cerner LIS with vendor provided chemistry instruments. Provide up to ten (10) hands on tutorials on IM Rule set usage, maintenance, and stewardship. Provide up to ten (10) hands on tutorials on creation and execution of test cases within the IM Rules engine. During testing and validation phase, provide remote or onsite guidance on validation techniques and assist with troubleshooting and/or rule modification, as needed, in preparation for Go-Live Provide guidance and assistance with design and configuration of up to twenty (20) unique Specimen Management workspaces to manage results that failed the Autoverification process. Provide up to thirty days of dedicated Autoverification go-live assistance to be used at VISN 15 s discretion. Post Go-Live Autoverification Maintenance Provide support and guidance during routine modifications of final Autoverification build, such as: Adding or removing tests to instrument menu and incorporation into Rules logic Modifying Rules logic cut-off values based on evolving lab SOP s. Tweak existing Specimen Management Workspaces, Moving Averages/Moving Medians, CAP eLab Solutions Connect, Notifier or Laboratory Intelligence configurations. Changes to User Security Group Roles Assistance, as needed, during annual Rule re-validation associated with regulatory requirements utilizing original project test script and validation plan. Two annual remote health checks per site to review workflow and provide enhancement or optimization ideas, as necessary. The Contractor shall provide upgrades to the middleware software. Contractor Middleware Management System - Automation Line Sufficient memory to store data requirements for operation of Primary Processing Automation Line. Supports workflow management that supports all integrated (linked) testing instrumentation and Primary Processing Automation Line. Contractor shall assist customer with optimizing operation and utilization of the data management system to fully integrate desired automation enhancing productivity and management of workflow. Middleware will be used as a pass through for analyzer Autoverification Rules. Vendor must supply a mobile (mounted on wheels) command center monitor at least 42 screen which will allow the technologists to monitor the instruments (split screen) and connections. Ability for instruments to maintain interface if automation system goes offline for repairs or maintenance. Equipment Preventative Maintenance/Repair Service The Contractor shall be able to provide emergency equipment repair and preventative maintenance on all primary and back-up instrumentation, primary processing automation line instrumentation and any incremental support/ancillary equipment, e.g. water system, printers, etc. offered according to the following terms: Preventative maintenance will be performed as frequently as published in manufacturer s operator s manual and within 2 weeks of the scheduled due date. A technical assistance center shall be available by telephone 24 hours per day, 7 days per week with a maximum call back response time of 1 hour(s). Equipment repair service shall be provided during core business hours. See TBD defining core business hours of each facility included in this solicitation. Certain circumstances may dictate the need for repair service to be conducted outside routine business hours. All such arrangements shall be coordinated between the Contractor and VA laboratory personnel. Perform QC and verify it passes before leaving or closing the service call. Parts replacement verification steps to verify new parts performance. This needs to be listed in the service report that is given to the site. Contractor must have the ability to remotely monitor all instruments on the line at one time in one place using via a Software to minimize instrument downtime and increase staff efficiency. This includes immediate notification of operating state, alerts, reagents and supplies status, QC and calibration inventory and status, and maintenance status. Analyzers must have minimal daily, weekly, and monthly maintenance downtime. Please provide total maintenance times, including washes and wait times, for daily, weekly and monthly maintenance. Please include any hands-on, automated non-maintenance activities. Equipment repair response time shall be no more than 24 hours. Please provide location of service personnel in relationship to the VISN 15 Medical Centers and Evansville Indiana CBOC. A malfunction incident report shall be furnished to the Laboratory upon completion of each repair call. The report shall include, as a minimum, the following: date and time notified date and time of arrival serial number, type, and model number of equipment time spent for repair, and proof of repair that includes documentation of a sample run of quality control verifying acceptable performance. Each notification for an emergency repair service call shall be treated as a separate and new service call. Vendor will supply any needles/probes or supplies necessary to keep the equipment operational. If upgrades or changes in technology render a piece of equipment no longer necessary, contractor shall remove said piece at contractor s expense. Please provide an independent quote for each site to potentially have their own service contract for both a general service contract agreement as well as a quote for an upgraded service agreement and what each entails. Hardware Features- The instrumentation shall have the following: All monitors/screens will clearly display information in all light conditions. A printer(s) that has the capability of printing a patient report with patient demographic information that includes minimally the patient s name and accession or unique identifier number (UID). An uninterruptible power supply (UPS) with line conditioner for each instrument provided. (This includes UPS units for sites with automation lines, specimen management systems, data management systems, refrigerated storage, etc.,) Each UPS must provide electrical power for a minimum of 15 minutes after electrical power fails and the system must allow for an automatic controlled shutdown to prevent damage to the instrument and data records. Method Performance/Validation Requirements Please provide the implementation and post-implementation plan for training, IT support and customer optimization Method performance/comparison shall be at the expense of the Contractor, shall include linearity material and reagents, and be consistent with current CLSI guidelines and related documents, College of American Pathologists (CAP) and The Joint Commission (TJC) standards and Federal regulations. All studies performed will be appropriate for the test menu of the respective laboratory to include serum, plasma, urine, and body fluids, as applicable. These validation requirements are applicable to all new testing analyzers. Correlation studies for each analyte. Vendor to provide all reagents, calibrators, and controls needed along with technical assistance to perform correlation studies from a single lot at no additional cost for new test methods or changes in test menus. (i.e., vendor is to provide all manpower and reagents/supplies to do correlation studies). A minimum 20 samples spanning the reportable range, shall be run comparing the present and the proposed method. In systems where multiple sampling modes exist, mode to mode correlation studies must also be performed. Contractor shall analyze results and provide statistical data to support acceptance of the new method for above studies. Statistics shall consist of at least mean, bias, slope, y-intercept, correlation coefficient, ROC analysis, and meet current standards defined by CLSI. Analytical Measurement Range (AMR) Validation shall be performed on proposed instrument(s) for each analyte to validate the reportable range. The material must have values, which are near the low, mid, and high values of the AMR and be of appropriate matrix for the clinical specimens assayed by that method. A 5-point linearity analysis that adheres to the Beer-Lambert Law and spans the entire range shall be performed as a minimum. Precision study using normal and abnormal control material. This shall include, at a minimum, within run precision study of 10 normal and 10 abnormal controls. Intra-VISN facility variations should be kept at an absolute minimum. Sensitivity. Sensitivity may be validated concurrently with correlation studies. Mathematical calculations to determine efficiency, sensitivity, false positive rate, and false negative rate are applied. Specificity Studies. A review of product literature and assay inserts to determine any adverse effects for increased bilirubin, hemolysis, lipemia, or other interfering substances. Carryover Studies. Successful carryover studies shall be completed by the contractor on all analyzers during installation. These studies shall be performed using either contractor developed program(s) or program(s) developed by a third party (CAP/CLSI). The programs shall be provided to each laboratory at no charge. Reference Range- A reference range must be determined for each test following CLSI guidelines. Samples used for the reference range study must be representative of the patient population being tested. Reference range assessment must be performed for each lab. One of the following protocols shall be used: A verification of the manufacturer s suggested reference range may be performed as long as the suggested range is based on a comparable population of test subjects. The manufacturer shall provide specific information defining how the suggested range was determined. A minimum of 20 reference individuals shall be used to verify the manufacturer s range. Any apparent outliers should be discarded, and new specimens obtained to provide a statistically valid verification. If the suggested manufacturer s range is not appropriate for the patient population, a reference range shall be established. Establishing a reference must follow CLSI guidelines. This requires a minimum of 120 reference individuals to be used to establish a reference range. The reference interval should be determined using the nonparametric method. If a laboratory is currently using the proposed instrument/reagent system, the in-use reference range can be transferred to the new system if a method comparison study between the two systems proves to be acceptable. If comparison studies are not acceptable, one of the two above items mu/t be performed. Data will be aggregated from each site to determine a VISN reference range. Reports- Support Features Commercial marketing. The equipment models being offered shall be in current production as of the date this offer is submitted. For purposes of this solicitation, current production shall mean that the clinical laboratory analyzer model is being offered as new equipment. Discontinued models that are only being made available as remanufactured equipment are not acceptable. Start-Up Reagents. The Contractor shall provide all reagents, calibrators, controls, consumable/disposable items, parts, accessories and any other item included on the list of supplies defined in the Federal Supply Schedule contract and required to establish instruments for operation for performance of acceptance testing. This applies to all equipment as well as additional or replacement equipment placed under the terms and conditions of this contract. The Contractor shall perform/assist, to the satisfaction of the Government, all validation studies including: precision, method comparison with current analyzer, accuracy (recovery), linearity (reportable range), calibration verification, verification of reference interval, and determination of sensitivity and specificity at no cost to the Government. The Contractor shall perform all of the statistical analysis as stated in the Method Performance/Validation section above and provide a hard copy of data in an organized, clearly comprehensible format. Commercial offerings - The Contractor shall provide operator and service manuals along with CLSI compliant procedures must be furnished for each instrument model supplied, unless provided electronically on board the instrument. Vendor to write Standard Operating Procedures for each assay in the laboratory template, to ensure that procedures are totally available prior to implementation. Documentation: A current editable, electronic (Microsoft Word) copy of the instrument operating guide(s) and procedures shall be provided to each site. The document(s) shall be formatted in accordance with current, approved CLSI guidelines. Electronic (CD Format). At a minimum, electronic copies of Safety Data Sheets (SDS) shall also be provided. Updates to all procedure manuals in Microsoft Word format and SDS sheets in electronic format shall be provided when package inserts are modified. Training. The Contractor shall provide an instrument training program. In addition to the training above the following shall be provided: Basic operator training shall be provided by Contractor on-site for all operators on all shifts, as applicable. Advanced training shall be provided on instrument troubleshooting, advanced middleware rules writing, data analytics, report writing and customization for 2 key operators if middleware is required for automation. If training program involves off-site travel, contractor shall cover the cost of airfare, room, and board for each participant. Upgrades - The Contractor shall provide upgrades to both the equipment hardware, and software in order to maintain the integrity of the system and the state-of the art technology, at no additional charge to the Government. These shall be provided as they become commercially available and at the same time as they are being provided to commercial customers. This requirement only applies to system upgrades that enhance the model of equipment being offered, i.e. new version of software, correction of hardware defect, upgrade offered to commercial customers at no additional charge, upgrade to replace model of equipment no longer Contractor supported, etc. Advanced notification and approval of the sites is necessary prior to doing software upgrades. Use of thumb drives at certain facilities require scanning prior to use by onsite OIT/BioMed. This does not refer to replacing the original piece of equipment provided under the contract; however, it does refer to significant changes in the hardware operational capability. Ancillary support equipment - The Contractor shall provide, install and maintain through the life of the contract , as indicated, any and all ancillary support equipment to fully operate the analyzer as defined in these specifications, e.g. cabinetry to support/house the analyzer (if necessary). Vendor must provide three-tiered utility carts for the computer and printer associated with the analyzers. Vendor must provide an Integrated high laboratory grade water system with provision for uninterrupted water supply during maintenance/change over. Service contract covering the term of the agreement must be included at no additional cost to the facilities. The water system company should be situated in close proximity to each individual facility rather than being organized on a regional basis. Meet the space limitations listed below (water system to be in separate location). Facilities Water Room Space Requirements Columbia VAMC  15 FT X 7 FT Rolla Super CBOC 5 FT x 3 FT Evansville HCC Remote location is an odd shape space but roughly 10 x12 , or adjacent to the analyzer at 3 x3 . Kansas City VAMC New water system in the works for the future; current space is 8 FT x 8 FT Leavenworth VAMC  5 FT x 3 FT Marion VAMC  Water System currently is in a room above the laboratory. There is the possibility of having one in the lab instead. It would need to feed the chemistry instruments, hematology instruments, and spigots in the lab. Space needed if moved to lab would depend on size of instruments, if it remains above the lab there is no limitation. Poplar Bluff VAMC  12 FT X 6 FT Cape Girardeau HCC 4 ft long x 7 ft tall x 16 inches wide (current unit hangs on wall) St. Louis VAMC  5.5 FT x 5.5 FT
Jefferson Barracks Division  Must be bench top space available 4 FT x 2.5 FT Topeka VAMC   5 FT x 4 FT
Wichita VAMC Water system is situated centrally between the two chemistry analyzers with feeds to both. There is also a connection to the house DI water whereby supply can be diverted to house system in the event of the water system failure. Foot print of current system is approximately 34 x 22 without connective paraphernalia. Vendor must include consumable polishers, filters, preventative maintenance and repair, etc.), printers and universal interface equipment, UPS Batteries, etc. for the life of the contract. In addition, the Contractor shall include all ancillary components that are customarily sold or provided with the model of equipment proposed, e.g. starter kits, tables/stands, etc. Characterization of waste The Contractor shall provide documentation that it has characterized the hazardous nature of all wastes produced by all equipment, devices, reagents, and discharges in accordance with the requirements of the Code of Federal Regulations Title 40 Protection of the Environment Part 261 et seq. and applicable state and local requirements. Documentation shall include a description of the characteristics of the hazardous waste produced as a byproduct of the instrument operations, Safety Data Sheets (SDS) meeting the requirements of the Occupational Safety and Health Administration (OSHA) and Environmental Protection Agency (EPA), the analytical process used to determine the hazardous nature and characteristics of the waste, and the analytical test results. Testing of hazardous waste is to be done in accordance with testing protocol specified for each individual waste as described in the Code of Federal Regulations Title 40 to make a determination if the waste is a hazardous waste or otherwise regulated. The determination and description shall address the following: Waste toxicity (Reference 40 CFR §261.11 and 40 CFR §261.24) Waste ignitability (Reference 40 CFR §261.21) Waste corrosivity (Reference 40 CFR §261.22) Waste reactivity (Reference 40 CFR §261.23) Hazardous waste from non-specific sources (F-listed) (Reference 40 CFR §261.31) Discarded commercial products (acutely toxic or P-listed and toxic or U-listed) (Reference 40 CFR §261.33) Solid Waste (Reference 40 CFR §261.2) Exclusions (Reference 40 CFR §261.4) Contractor shall provide a description of all wastes the process or equipment may discharge so that the facility can determine whether the discharge meets Local Publicly Owned Treatment Works (POTW), State and Federal discharge requirements. At a minimum the characteristics of ignitability, corrosivity, reactivity and toxicity as defined in 40 CFR §261 must be determined and documented. Any mercury containing reagents must be identified in any concentrations. All test results shall be provided. All listed chemicals (F, U, K and P) found in 40 CFR §261 shall be provided in product information and their concentrations documented. For those materials with a positive hazardous waste determination, a mechanism for the laboratory to meet local discharge requirements (i.e. mercury, thimerosol and formaldehyde) must be developed and SDS sheets must be provided in advance for review. At a minimum, documentation shall include, but not be limited to the concentration/measures of the elements and parameters listed below and must be included with vendor response: Barium (Total) Cadmium (Total) Chromium (Total) Copper (Total) Cyanide (Total) Lead (Total) Mercury (Total) Nickel (Total) Silver (Total) Zinc (Total) Arsenic (Total) Selenium (Total) Tin (Total) pH Flash point (to higher than 200°F) BOD; biochemical oxygen demand The documentation the contractor provides will be used to work with the VAMC and the public and/or private organization (e.g., POTW) to determine whether or not the waste from each device can legally be disposed of via the sewerage system. Implementation/transition timeframe - The implementation of the services/requirements described in this solicitation shall be completed no later than 120 days after the award of the contract. This timeline is based on a reasonable attempt of the Contractor to complete all of the necessary implementation requirements within the stated timeframe. Contractor shall not be penalized for implementation timelines that extend beyond the 120-day timeframe if the extension is through no fault of the Contractor and is a result of delays due to the Government. Upon award of a contract, the transition period for the awarded contract to have all equipment and peripherals installed and operational shall be from date of award through 120 days. During this same period all initial training of VA personnel in the operation and maintenance of said award shall also be completed. Contractor shall provide with its quotation an implementation plan for installation of new equipment. Contractor s submitted plan shall not exceed 120 days for the transition of all services under the awarded contract including installation and training of personnel, transition of all testing materials, reagents, and supplies, etc., performance of all correlations and validations. Failure of the Contractor to conform to the transition period shall be considered as sufficient cause to terminate contract for cause under the Termination for Cause clause of the contract. . Standard and Quality of Performance: Will be in solicitation
More opportunities from Department Of Veterans Affairs → 255-NETWORK Contract Office 15 (36C255)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
